43.4 F
New York
Monday, January 18, 2021

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Finding Its Footing

Must read

Why Is Everyone Talking About Alpine 4 Technologies Ltd (OTCMKTS:ALPP) Stock?

Investors who are looking for fast-moving stocks have had have made options in recent days. One stock that certainly stands out is...

Nano One Materials Corp (OTCMKTS:NNOMF) Signs Cathode Evaluation Agreement: Stock Reacts

Over the past week, there have been many stocks that have managed to generate significant gains and one of those is Nano...

Grayscale Bitcoin Trust (OTCMKTS:GBTC) Extends Rally As Bitcoin Jumps

One of the bigger stories of the year so far has been the massive gains made by Bitcoin. This week BTC hit...

Plyzer Technologies Inc (OTCMKTS:PLYZ) Gains Momentum on High Volume: Now What?

One of the more notable gainers this week on the OTC is Plyzer Technologies Inc (OTCMKTS:PLYZ). The stock was in focus among...

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) is finally bouncing upward after a decline from highs in late March. Shares were trading as high as $7.00 per share, but lost 90% in the preceding months. As it sits, CNBX is $1.00 per share with a market cap of $163.6 million and 114.68 million shares outstanding. The company released news back in February and shares exploded and then plunged. They addressed the volatility reaching out to shareholders, but seemed to be just as confused by the market volume and volatility. However, CNBX may have found footing after the recent turn last week.

During the February volatility, CNBX said, “…We wish to inform shareholders and the public at large that is acutely aware of the significant increase in our share volume this past month and we were contacted by OTC Markets on February 21st regarding this matter”.

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) and CEO, Itamar Borochov, said at the time, “We are very aware of the increased interest in our science and its apparent results in the marketplace.” I wish to reiterate that there is neither any undisclosed material information available nor any paid promotional activity or Investor Relations for the Company at all. The sole source of the Company’s public information has been press releases which we, the Company, authorize and release ourselves”.

Subscribe below and we’ll keep you on top of what’s happening before $CNBX stock makes its next move.

CNBX believes that its planned commercialization of its Liquid Biopsy Diagnostic tests to the recent increased activity. As stated in that release, CNBX started to test patients in March. The company believes the rapidly increasing awareness and interest in companies operating in the field of cannabinoid-based biotechnology has simply created heightened demand.

In April, the company announced that it received the final report of the research held in the Technion Israel Institute of Technology, in which the antitumor activity of cannabinoids was reflected in several types of cancer (breast, ovarian, colon, pancreatic, gastric, glioblastoma).

The results which were obtained, using High Throughput Screening technology, and could clearly indicate that the company’s cannabinoid compounds caused apoptosis in all cancer types with no effect on healthy normal cells.

Itamar Borochov, CEO of Cannabics Pharmaceuticals said, “The results from this research strengthens our vision of creating anticancer treatments based on natural cannabis medicine”.

The company provided an update saying, “Cannabis has the potential of being a natural cancer attenuator comprising numerous active compounds which interact with human cells in a complex manner. Understanding the biological mechanism is a long and profound process, yet, utilizing diagnostic lab tests and clinical studies this potential can be unraveled “.

The Bottom Line: Cannabics Pharmaceuticals Inc. (OTCMKTS:CNBX) is taking steps to secure operating capital. CNBX announced in May that it entered into a securities purchase agreement with D-Beta One EQ, Ltd., who purchased 3,000,000 shares of common stock at a $1.00 per share, for aggregate proceeds of $3.0 million and may purchase up to an additional 1,500,000 shares at $2.00 over the next 12 months. This stock may have found a base point and could be finally ready to hold its ground. We will keep you updated as news comes in. For continuing coverage on shares of $CNBX stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!

Latest article

Ozop Energy Solutions Inc (OTCMKTS:OZSC) Remains Volatile: Stock in Focus

Those who are looking to discover stocks that may have made big moves over the course of the past week could consider...

Data Storage Corp (OTCMKTS:DTST) Gets Sudden Attention: What’s The Buzz?

One of the stocks to have made significant gains this week was that of Data Storage Corp (OTCMKTS:DTST). The Data Storage Corporation...

A Closer Looks at American Battery Metals Corp (OTCMKTS:ABML) Developments

American Battery Metals Corp (OTCMKTS:ABML) is one of the stocks to have been in focus among investors over the course of the...

Why is Grayscale Ethereum Trust (ETH) (OTCMKTS:ETHE) In a Bearish Trend?

The Bitcoin rally over the past weeks has taken the crypto space by storm. However, it should not be forgotten that Ethereum,...

Curaleaf Holdings (OTCQX:CURLF) Continues to Hit New Highs: Next Move?

The cannabis sector has had its ups and downs over the last year, but there are certain stocks that are almost always...